濮阳东方医院男科割包皮口碑放心很好濮阳东方妇科医院评价如何,濮阳东方医院看妇科病价格偏低,濮阳东方男科技术可靠,濮阳东方医院做人流手术很权威,濮阳东方妇科挂号电话,濮阳东方医院做人流价格,濮阳东方医院妇科做人流安全吗

BEIJING, June 26 (Xinhua) -- A drama honoring an archivist who had devoted himself to the Chinese People's Liberation Army (PLA)'s archive work was staged Saturday evening in Beijing.The drama, "Sheng Ming Dang An," or "Archives of Life," tells the life story of Liu Yiquan who had worked as a file clerk and later a consultant at the PLA Archives for about 38 years.Liu had collected more than 830,000 pieces of military archives, which was regarded as a special contribution to the army. Li Changchun (L, front), a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee, congratulates actors on the successful performance of drama "life archives" in Beijing, capital of China, June 25, 2011.Despite being diagnosed with terminal cancer in 2008, Liu continued to work hard. He died on Jan. 28, 2010, at the age of 59.Li Changchun, a Standing Committee member of the Political Bureau of the Communist Party of China (CPC) Central Committee, joined the audience of the drama on Saturday.Li later said the drama was touching and significant in reflecting the model role of CPC members ahead of the 90th founding anniversary of the CPC.Liu Yiquan was also honored by the U.S. military authorities for his role in helping identify some key documents that led to the repatriation of the remains of the United States personnel who disappeared during and after the Korea War (1950-1953). 

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

SYDNEY, Aug. 5 (Xinhua) -- The Western Australian Government announced on Friday that 14 new substances linked to the manufacture of the synthetic drug Kronic would be banned from Friday midnight.The State Mental Health Minister Helen Morton told the Australian Broadcasting Corporation (ABC) Radio on Friday morning that two substances found in Kronic Black would be banned from midnight tonight (Friday night), as well as another 12 others found in synthetic cannabis products.People caught in possession of banned synthetic cannabis face hefty fines or possible jail sentences.The government of Western Australia (WA) in June listed a number of synthetic cannabis products, including Kronic, Voodoo and Mango Kush, as illegal substances.But synthetic drug makers have since released a new product, Kronic Black Label, using a different blend of chemicals they say make it still legal to sell.Police suspect the death of a 38-year-old Perth man is linked to his smoking of the synthetic cannabis product Kronic Black Label, which contains two of the 14 substances to be banned.The man, from Hillman in Perth's south, was rushed to Rockingham Hospital on Thursday night after suffering a suspected cardiac arrest, but he later died.Police now are conducting an investigation to identify the cause of the man's death.The Australian Medical Association has warned that synthetic drugs could cause severe paranoia, anxiety and panic attacks.

LOS ANGELES, July 18 (Xinhua) -- At least 70 genetic mutations may be involved in the formation of colon cancer, far more than scientists previously thought, a new study suggests.The study by researchers at University of Texas (UT) Southwestern Medical Center contradicts previous thinking that only a few mutated genes may play a role in the development of colon cancer."The ways we've been treating patients up to now is to just go after one target when we should be going after three to four different pathways simultaneously," said Dr. Jerry W. Shay, vice chairman and professor of cell biology at UT Southwestern.The new study identified 65 candidate genes and at least five passenger genes whose mutations play significant roles in cancer development. Inactivating the function of any of these tumor- suppressing genes led to a key step in cancer development called anchorage-independent growth, meaning cells piled up on top of each other rather than aligning neatly.According to previous studies, there were 151 candidate genes and that mutations in just eight to 15 of them would lead to cancer. There were 700 other genes classified as passenger genes whose mutations were incidental to cancer growth.Current cancer treatments target just one or two known cancer- driver genes. While patients may get transient tumor burden reduction, almost universally tumor growth returns."Those numbers are dead wrong," Dr. Shay said, suggesting a new approach to colon cancer treatments targeting multiple genes and pathways simultaneously.The next step is further research to classify more accurately which genes drive cancer and which are merely passengers, the researchers said.Study findings were published in the July 2011 Cancer Research (Priority Reports).

SAN FRANCISCO, June 17 (Xinhua) -- A new research released on Friday shows that smartphone users in the United States are consuming more data than ever, growing by 89 percent in the first quarter on a year-over-year basis.According to data from marketing company Nielsen, the amount of data the average smartphone user consumes per month is 435 Megabytes (MB) in the first quarter of 2011, compared with 230 MB in the same period last year.As for the distribution of data consumption, data usage for the top 10 percent of smartphone users is up 109 percent while the top 1 percent has grown their usage by 155 percent from 1.8 Gigabytes (GB) in the first quarter of 2010 to over 4.6 GB this year.The research said consumers with iPhones and Android smartphones consume the most data, which is driven by app-friendly operating systems like Apple's iOS and Google's Android. Windows Phone 7 users doubled their usage over the fourth quarter of 2010 and the first quarter of 2011, perhaps due to growth in the number of applications available.Meanwhile, the cost per MB for smartphones has dropped by 46 percent over the last year, from 14 cents per MB to 8 cents, said the research.According to Internet marketing research company comScore, in the first quarter of 2011, 234 million Americans ages 13 and older used mobile devices, 74,6 million of whom are smartphone users.